DEXTROSE injection, solution

Land: Verenigde Staten

Taal: Engels

Bron: NLM (National Library of Medicine)

Werkstoffen:

DEXTROSE MONOHYDRATE (UNII: LX22YL083G) (ANHYDROUS DEXTROSE - UNII:5SL0G7R0OK)

Beschikbaar vanaf:

HF Acquisition Co LLC, DBA HealthFirst

Toedieningsweg:

INTRAVENOUS

Prescription-type:

PRESCRIPTION DRUG

therapeutische indicaties:

50% Dextrose Injection is indicated in the treatment of insulin hypoglycemia (hyperinsulinemia or insulin shock) to restore blood glucose levels. The solution is also indicated, after dilution, for intravenous infusion as a source of carbohydrate calories in patients whose oral intake is restricted or inadequate to maintain nutritional requirements. Slow infusion of hypertonic solutions is essential to insure proper utilization of dextrose and avoid production of hyperglycemia. A concentrated dextrose solution should not be used when intracranial or intraspinal hemorrhage is present, nor in the presence of delirium tremens if the patient is already dehydrated. Dextrose injection without electrolytes should not be administered simultaneously with blood through the same infusion set because of the possibility that pseudoagglutination of red cells may occur.

Product samenvatting:

50% DEXTROSE INJECTION, USP is supplied in the following dosage forms. NDC 51662-1215-1 50% DEXTROSE INJECTION, USP 25grams/50mL (0.5g/mL) VIAL HF Acquisition Co LLC, DBA HealthFirst Mukilteo, WA 98275 Also supplied in the following manufactures dosage forms 50% Dextrose Injection, USP is supplied in single-dose containers as follows: Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. Protect from freezing. Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.]

Autorisatie-status:

New Drug Application

Productkenmerken

DEXTROSE- DEXTROSE INJECTION, SOLUTION
HF ACQUISITION CO LLC, DBA HEALTHFIRST
----------
50% DEXTROSE INJECTION, USP 25GRAMS/50ML (0.5G/ML) VIAL
SPL UNCLASSIFIED
NOTE: This solution is hypertonic — See WARNINGS and PRECAUTIONS.
LifeShield™ Abboject® Syringe Fliptop Container
Ansyr™ Plastic Syringe
Ansyr™II Plastic Syringe
Rx only
DESCRIPTION
50% Dextrose Injection, USP is a sterile, nonpyrogenic, hypertonic
solution of dextrose
in water for injection for intravenous injection as a fluid and
nutrient replenisher.
Each mL of fluid contains 0.5 g dextrose, hydrous which delivers 3.4
kcal/gram. The
solution has an osmolarity of 2.53 mOsmol/mL (calc.), a pH of 4.2 (3.2
to 6.5) and may
contain sodium hydroxide and/or hydrochloric acid for pH adjustment.
The solution contains no bacteriostat, antimicrobial agent or added
buffer (except for pH
adjustment) and is intended only for use as a single-dose injection.
When smaller doses
are required, the unused portion should be discarded with the entire
unit.
Dextrose, USP is chemically designated C6H12O6 ∙ H2O (D-glucose
monohydrate), a
hexose sugar freely soluble in water. Dextrose, hydrous has the
following structural
formula:
Water for Injection, USP is chemically designated H2O.
The syringe is molded from a specially formulated polypropylene. Water
permeates from
inside the container at an extremely slow rate which will have an
insignificant effect on
solution concentration over the expected shelf life. Solutions in
contact with the plastic
container may leach out certain chemical components from the plastic
in very small
amounts; however, biological testing was supportive of the safety of
the syringe
material.
CLINICAL PHAMACOLOGY
When administered intravenously this solution restores blood glucose
levels in
hypoglycemia and provides a source of carbohydrate calories.
Carbohydrate in the form of dextrose may aid in minimizing liver
glycogen depletion and
exerts a protein-sparing action. Dextrose injection undergoes
oxidation to carbon
dioxide and water.
Water